Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have stopped having periods as a result of chemotherapy (known as chemotherapy-induced amenorrhea) and who have requested fertility follow-up care after cancer treatment at the University Hospital of Lille, France
- Women who are between 25 and 35 years old at the time of joining the trial
- Women who received a specific chemotherapy plan made up of FEC 100 (3 cycles) followed by docetaxel (3 cycles)
Who may not be able to join:
- Women whose periods have not stopped as a result of chemotherapy
- Women who do not wish to take part in the study
- Women who are older than 35 years at the time of joining the trial
- Women who received a different chemotherapy plan than the one specified above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pascal PIGNY, MD,PhD, University Hospital, Lille
Phone: 0320445962
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of IL-6 levels at the end of chemotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.